Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance

NCT06202911 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06202911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06202911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2023
Completion date
March 30, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis, oral n-acetyl cysteine, preterm neonates and feeding intolerance